Clinical Trials Logo

Clinical Trial Summary

This is a multicentre, non-interventional, single arm study that aims to describe the treatment patterns in France: patients' characteristics, disease characteristics, prior treatments for Severe chronic rhinosinusitis with nasal polyposis and treatment prescription modalities. As well as to assess the clinical outcome after initiation of dupilumab (Dupixent®) and safety of the product during the two years of treatment


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06393946
Study type Observational
Source Sanofi
Contact Trial Transparency email recommended (Toll free for US & Canada)
Phone 800-633-1610
Email Contact-US@sanofi.com
Status Recruiting
Phase
Start date October 20, 2023
Completion date September 18, 2026